China Advanced Radiotherapy Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Advanced Radiotherapy Market was valued at USD 1.22 billion in 2025 and is projected to reach USD 1.98 billion by 2032, growing at a CAGR of approximately 7.2% during 2026–2032.
China Advanced Radiotherapy Market Highlights
| Report Metric | Details |
| Report Name | China Advanced Radiotherapy Market |
| Market Size 2025 | USD 1.22 billion |
| Market Size 2032 | USD 1.98 billion |
| Absolute Growth 2025–2032 | USD 0.76 billion |
| CAGR 2026–2032 | 7.2% |
| Peak Annual Growth | 9.8% in 2032 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Advanced Radiotherapy Market, 2025 | Proton Beam Therapy (38% share) |
| Leading Therapy Type, 2025 | Particle Therapy (43% share) |
| Leading Technology Used, 2025 | Cyclotron Accelerator (36% share) |
| Leading Delivery Method, 2025 | External Beam (36% share) |
| Leading End User, 2025 | Oncology Hospitals (43% share) |
| Fastest-Growing Advanced Radiotherapy Market | Image-Guided Radiotherapy (IGRT) (8.9% CAGR) |
| Fastest-Growing Therapy Type | X-Ray/MRI Integration (8.8% CAGR) |
| Fastest-Growing Technology Used | Real-Time Imaging (9.2% CAGR) |
| Fastest-Growing Delivery Method | Precision Mapping (9.2% CAGR) |
| Fastest-Growing End User | Cancer Treatment Centers (8.5% CAGR) |
| Growing Sector | Oncology |
| Key End Users | Oncology Hospitals, Cancer Treatment Centers, Specialized Clinics, Neurosurgical Units |
China Advanced Radiotherapy Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The following table presents the estimated annual growth rate for each year together with the principal factor influencing market performance.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 6.7 | The market experienced strong demand due to rising cancer cases and the 'Cancer Prevention and Control Plan'. |
| 2023 | 6.0 | Growth slowed as hospitals adjusted to new treatment protocols and the National Standard for Radiotherapy Equipment was updated. |
| 2024 | 5.2 | Market expansion continued to slow as facilities faced resource allocation challenges and regulatory adjustments. |
| 2025 | 5.8 | Demand increased as hospitals adopted advanced technologies and the Cancer Treatment Centers expanded their services. |
| 2026 | 7.5 | Investment in new technologies is expected to spur growth as urban centers enhance their capabilities through government initiatives. |
| 2027 | 6.5 | Growth is projected to slow as hospitals face delays in equipment procurement and installation from the National Medical Products Administration. |
| 2028 | 4.9 | Market growth is expected to decelerate as urban centres reach saturation in advanced treatment options and funding limitations arise. |
| 2029 | 6.9 | Demand is expected to rise as more cancer treatment centres open in underserved regions, improving access to care. |
| 2030 | 8.8 | Investment in technology and infrastructure improvements will boost market growth, supported by the 'Healthy China Initiative'. |
| 2031 | 5.8 | Growth is projected to slow as hospitals adjust to regulatory changes and funding limitations from the Ministry of Health. |
| 2032 | 9.8 | The market is expected to peak as advancements in treatment technologies gain widespread adoption, particularly in urban areas. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Advanced Radiotherapy Market Synopsis
The China Advanced Radiotherapy Market encompasses cutting-edge cancer treatment technologies that utilise high-energy radiation to target and destroy cancer cells. This market includes therapies such as Proton Beam Therapy and Image-Guided Radiotherapy, essential for effective cancer treatment. The oncology sector is robust, with over 2,000 hospitals providing advanced services. The increasing incidence of cancer, with approximately 1.5 million new cases reported in 2022, drives demand for these technologies. The 'Cancer Prevention and Control Plan' aims to improve treatment accessibility, further fuelling the market's growth.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising cancer incidence and treatment advancements drive demand for advanced radiotherapy. | Driver | High | Proton Beam Therapy |
| Investment in technology upgrades enhances treatment capabilities in hospitals. | Driver | High | Image-Guided Radiotherapy (IGRT) |
| Increasing focus on cancer treatment accessibility creates opportunities for new facilities. | Opportunity | High | Cancer Treatment Centers |
| The growing demand for precision therapies opens new markets for advanced equipment. | Opportunity | High | Oncology Hospitals |
| High costs of advanced equipment can limit accessibility for smaller facilities. | Restraint | High | Brachytherapy |
| Regulatory hurdles can delay the approval of new treatment technologies. | Restraint | Medium | Stereotactic Radiosurgery (SRS) |
| Limited funding for cancer treatment can restrict hospital upgrades and expansions. | Challenge | High | Proton Beam Therapy |
| Supply chain disruptions can delay the delivery of critical radiotherapy equipment. | Challenge | Medium | Particle Therapy |
Evaluation of Drivers in China Advanced Radiotherapy Market (2026–2032)
The factors lifting demand, and the evidence behind each, are summarised below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising cancer cases increase the need for advanced treatment options. | Proton Beam Therapy | Approximately 1.5 million new cancer cases were reported in 2022, driving demand. |
| Investment in hospital infrastructure supports advanced treatment capabilities. | Image-Guided Radiotherapy (IGRT) | Urban cancer treatment centers are increasingly adopting IGRT technologies, with adoption rates exceeding 70%. |
| Technological advancements improve treatment precision and patient outcomes. | Brachytherapy | Over 30% of prostate cancer treatments utilise brachytherapy in specialized clinics, enhancing treatment effectiveness. |
| Government initiatives promote the establishment of new cancer treatment facilities. | Cancer Treatment Centers | The 'Healthy China Initiative' aims to increase advanced radiotherapy facilities in rural areas by 2025. |
| Integration of robotic systems improves treatment accuracy and efficiency. | Stereotactic Radiosurgery (SRS) | Robotic Arm Systems are increasingly integrated into urban hospital practices, improving treatment delivery. |
Market growth in China for Advanced Radiotherapy rests on substantial investments in hospital infrastructure, technological advancements, and rising end-use demand. The number of new cancer cases reported reached 1.5 million in 2022, creating a pressing need for effective treatment options. Urban cancer treatment centres are increasingly adopting advanced technologies, improving the precision of treatment delivery. The integration of robotic systems into treatment practices is also improving accuracy and efficiency, encouraging more hospitals to invest in these technologies.
Evaluation of Restraints in China Advanced Radiotherapy Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| High costs of advanced radiotherapy equipment limit accessibility for smaller hospitals. | Brachytherapy | The average treatment cost for advanced radiotherapy is approximately 100,000 yuan. |
| Regulatory hurdles can delay the approval of new treatment technologies. | Stereotactic Radiosurgery (SRS) | The National Medical Products Administration regulates advanced radiotherapy equipment. |
| Limited funding for cancer treatment restricts hospital upgrades and expansions. | Proton Beam Therapy | In 2023, the government allocated a budget of 500 million yuan for cancer treatment improvements. |
| Supply chain disruptions can delay the delivery of critical radiotherapy equipment. | Particle Therapy | Ongoing global supply chain issues affect timely access to advanced machinery. |
| Resource allocation challenges hinder the implementation of new treatment protocols. | Image-Guided Radiotherapy (IGRT) | Hospitals faced challenges in adjusting to new treatment protocols and equipment upgrades. |
China Advanced Radiotherapy Market Challenges
In China, the advanced radiotherapy market contends with fierce competition among over 2,000 oncology hospitals, which drives down service prices and diminishes profitability for providers. The 1.5 million new cancer cases reported in 2022 strain treatment capacity, resulting in longer wait times for patients seeking advanced radiotherapy. The average treatment cost of 100,000 yuan presents a considerable financial burden for buyers, particularly in rural regions where access to facilities is limited. Regulatory hurdles from the National Medical Products Administration can delay the introduction of new technologies, limiting hospitals' ability to provide the latest treatment options.
Trends in the China Advanced Radiotherapy Market
Buyers and suppliers in the China Advanced Radiotherapy Market are adjusting to the following trends.
- Shift from Traditional to Advanced Radiotherapy Technologies: Since 2021, the uptake of advanced technologies like Proton Beam Therapy has risen. Major cities such as Beijing and Shanghai are at the forefront of this trend, with over 150 accredited cancer treatment centres now operational.
- Increased Integration of Robotic Systems: The adoption of robotic systems in radiotherapy practices commenced in 2022, enhancing precision in treatment delivery. As of 2023, urban hospitals have reported a 70% adoption rate of these technologies.
- Expansion of Cancer Treatment Centers in Rural Areas: The 'Healthy China Initiative' launched in 2021 aims to boost the number of advanced radiotherapy facilities in rural regions. By 2025, the goal is to establish 200 new centres, improving access to treatment.
- Growing Demand for Image-Guided Radiotherapy: The swift adoption of Image-Guided Radiotherapy (IGRT) has been apparent since 2022, with urban cancer treatment centres increasingly implementing these technologies. The adoption rate is projected to surpass 70% in urban areas.
Investment Opportunities in the China Advanced Radiotherapy Market
Some of the investment opportunities in the China Advanced Radiotherapy Market are mentioned below.
- Oncology Hospitals Seeking Advanced Equipment: Oncology hospitals in urban areas are actively pursuing advanced radiotherapy equipment. With over 2,000 oncology hospitals in China, there is a clear opportunity to supply advanced technologies.
- Investment in Cancer Treatment Centers: Cancer treatment centres are broadening their services to meet escalating demand. The government aims to establish 200 new centres by 2025, presenting opportunities for partnerships and investments.
- Supply of Robotic Systems for Enhanced Precision: The demand for robotic systems in radiotherapy practices is on the rise. Urban hospitals are integrating these systems, creating opportunities for suppliers of advanced robotic technologies.
- Entry into the Advanced Radiotherapy Equipment Market: There is a growing need for advanced radiotherapy equipment in China. Establishing joint ventures with local manufacturers can facilitate market entry and compliance with regulations.
Government Initiatives in the China Advanced Radiotherapy Market
The 'Cancer Prevention and Control Plan (2021-2025)' by the National Health Commission aims to improve cancer treatment accessibility and quality across China. This plan focuses on increasing the availability of advanced radiotherapy technologies in hospitals nationwide. Additionally, the 'National Standard for Radiotherapy Equipment' was updated in 2022 by the National Medical Products Administration to ensure safety and efficacy in treatment. These measures are important for maintaining high standards in cancer care and ensuring that patients have access to the latest technologies.
In 2023, the Ministry of Science and Technology initiated the 'Advanced Radiotherapy Research Program' with a budget of 200 million yuan to support innovation in cancer treatment technologies. This program aims to fund research and development in advanced radiotherapy methods. The National Health Commission oversees the implementation of cancer treatment guidelines, ensuring that hospitals adhere to the latest standards. Furthermore, the 'National Radiotherapy Equipment Upgrade Program' launched in 2021, with a budget of 300 million yuan, aims to improve technology in hospitals nationwide.
Future Insight of the China Advanced Radiotherapy Market
The advanced radiotherapy market in China is set for substantial evolution by 2032, driven by the expansion of accredited cancer treatment centres and the integration of robotic systems in urban hospitals. The 'Cancer Prevention and Control Plan' aims to improve treatment access, particularly in underserved areas, enhancing patient care. By 2025, infrastructure improvements will facilitate better service delivery. With a budget of 500 million yuan allocated for cancer treatment enhancements, suppliers can expect increased demand for advanced therapies that address specific patient requirements.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By Advanced Radiotherapy Market – Proton Beam Therapy Dominated, Image-Guided Radiotherapy (IGRT) Expected to Grow Fastest
According to Ravi Bhandari, Research Head at 6Wresearch, Proton Beam Therapy took a 38% share of advanced radiotherapy market in 2025, more than any other category. Proton Beam Therapy holds the largest share because it is a primary method for treating tumours with high precision, making it a preferred choice in over 2,000 oncology hospitals across China. Its effectiveness in complex cases drives widespread adoption in major cities like Beijing and Shanghai. Image-Guided Radiotherapy (IGRT) is set to record the highest CAGR in this split, 8.9% over 2026–2032. Image-Guided Radiotherapy (IGRT) is witnessing rapid growth as hospitals increasingly implement this technology to enhance treatment accuracy, with adoption rates exceeding 70% in urban centres. This trend will likely continue as facilities aim to improve patient outcomes and operational efficiency. Suppliers should focus on enhancing IGRT offerings to meet the growing demand for precision in cancer treatment.
By Therapy Type – Particle Therapy Dominated, X-Ray/MRI Integration Expected to Grow Fastest
The largest therapy type category in 2025 was Particle Therapy, with a 43% share of total revenue. Particle Therapy captures a significant share as it is specifically designed for treating certain cancers, appealing to a targeted patient demographic. Its effectiveness in delivering high doses of radiation precisely to tumours has made it a preferred choice in advanced oncology practices. Over 2026–2032, X-Ray/MRI Integration is expected to post the fastest growth, at a CAGR of 8.8%. X-Ray/MRI Integration is growing quickly as it provides essential imaging support that complements therapy, streamlining treatment planning processes. This integration is becoming increasingly important as facilities aim to improve diagnostic accuracy and treatment outcomes. Buyers will benefit from investing in integrated therapy solutions that combine imaging and treatment capabilities.
By Technology Used – Cyclotron Accelerator Dominated, Real-Time Imaging Expected to Grow Fastest
With a 36% revenue share in 2025, Cyclotron Accelerator was the largest technology used category. Cyclotron Accelerator leads the market due to its crucial role in generating proton beams necessary for advanced radiotherapy treatments. This technology is foundational in oncology hospitals, ensuring high-quality treatment delivery for patients. The quickest growth will come from Real-Time Imaging, forecast to expand at a CAGR of 9.2% between 2026 and 2032. Real-Time Imaging is rapidly gaining traction as it enhances the ability to monitor treatment progress, which is vital for patient safety and effectiveness. The growing emphasis on real-time data in clinical settings is propelling its adoption across various facilities. Suppliers should prioritise the development of real-time imaging technologies to align with the evolving needs of treatment centres.
By Delivery Method – External Beam Dominated, Precision Mapping Expected to Grow Fastest
External Beam held a 36% share of the China Advanced Radiotherapy Market by delivery method in 2025. External Beam is the most widely used delivery method, accounting for a large share as it effectively targets tumours while minimising damage to surrounding tissues. Its established presence in oncology hospitals ensures consistent patient access to this treatment modality. Precision Mapping is projected to grow fastest, at a CAGR of 9.2% during 2026–2032. Precision Mapping is becoming increasingly popular as it aids in treatment planning, allowing for more tailored approaches to patient care. As hospitals focus on optimising treatment protocols, the demand for precision mapping is expected to rise significantly. Buyers should consider investing in advanced planning tools that enhance the delivery of external beam therapy.
By End User – Oncology Hospitals Dominated, Cancer Treatment Centers Expected to Grow Fastest
Oncology Hospitals accounted for a 43% market share by end user in 2025. Oncology Hospitals dominate the market due to their comprehensive capabilities in providing advanced radiotherapy services, catering to a large patient base. With over 1.5 million new cancer cases reported annually, these facilities are essential in addressing the growing demand for treatment. Cancer Treatment Centers are set to record the highest CAGR in this split, 8.5% over 2026–2032. Cancer Treatment Centers are experiencing rapid growth as they specialise in delivering targeted cancer care, making them increasingly vital in urban healthcare settings. Their focus on comprehensive treatment plans is attracting more patients seeking advanced therapies. Suppliers should target oncology hospitals and cancer treatment centres to meet the rising demand for advanced radiotherapy solutions.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Advanced Radiotherapy Market Outlook
- Market Size of China Advanced Radiotherapy Market, 2025
- Forecast of China Advanced Radiotherapy Market, 2032
- Historical Data and Forecast of China Advanced Radiotherapy Revenues & Volume for the Period 2022 - 2032F
- China Advanced Radiotherapy Market Trend Evolution
- China Advanced Radiotherapy Market Drivers and Challenges
- China Advanced Radiotherapy Price Trends
- China Advanced Radiotherapy Porter's Five Forces
- China Advanced Radiotherapy Industry Life Cycle
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Advanced Radiotherapy Market for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Proton Beam Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Image-Guided Radiotherapy (IGRT) for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Stereotactic Radiosurgery (SRS) for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Brachytherapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Therapy Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Particle Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By X-Ray/MRI Integration for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By High-Dose Radiation for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Internal Radiation for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Technology Used for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Cyclotron Accelerator for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Real-Time Imaging for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Robotic Arm Systems for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Radioactive Seeds for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Delivery Method for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By External Beam for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Precision Mapping for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By One-Time Focused Dose for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Catheter Implantation for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Oncology Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Cancer Treatment Centers for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Neurosurgical Units for the Period 2022 - 2032F
- Historical Data and Forecast of China Advanced Radiotherapy Market Revenues & Volume By Specialized Clinics for the Period 2022 - 2032F
- China Advanced Radiotherapy Import Export Trade Statistics
- Market Opportunity Assessment By Advanced Radiotherapy Market
- Market Opportunity Assessment By Therapy Type
- Market Opportunity Assessment By Technology Used
- Market Opportunity Assessment By Delivery Method
- Market Opportunity Assessment By End User
- China Advanced Radiotherapy Top Companies Market Share
- China Advanced Radiotherapy Competitive Benchmarking By Technical and Operational Parameters
- China Advanced Radiotherapy Company Profiles
- China Advanced Radiotherapy Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments.
By Advanced Radiotherapy Market
- Proton Beam Therapy
- Image-Guided Radiotherapy (IGRT)
- Stereotactic Radiosurgery (SRS)
- Brachytherapy
By Therapy Type
- Particle Therapy
- X-Ray/MRI Integration
- High-Dose Radiation
- Internal Radiation
By Technology Used
- Cyclotron Accelerator
- Real-Time Imaging
- Robotic Arm Systems
- Radioactive Seeds
By Delivery Method
- External Beam
- Precision Mapping
- One-Time Focused Dose
- Catheter Implantation
By End User
- Oncology Hospitals
- Cancer Treatment Centers
- Neurosurgical Units
- Specialized Clinics
